Symphony Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Symphony Asset Management's BMY Position: Q3 2018 in Review
Symphony Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 15,193 shares — an estimated $961K sold.
Symphony Asset Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $2.51M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Symphony Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
- Symphony Asset Management sold 15,193 Bristol-Myers Squibb shares in Q3 2018, an estimated $961K.
- Symphony Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
- Symphony Asset Management's Bristol-Myers Squibb position peaked at $2.51M in Q3 2017.
- 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.